The Pathogenic Mechanism of the Mycobacterium ulcerans Virulence Factor, Mycolactone, Depends on Blockade of Protein Translocation into the ER
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Infection with Mycobacterium ulcerans is characterised by tissue necrosis and immunosuppression due to mycolactone, the necessary and sufficient virulence factor for Buruli ulcer disease pathology. Many of its effects are known to involve down-regulation of specific proteins implicated in important cellular processes, such as immune responses and cell adhesion. We have previously shown mycolactone completely blocks the production of LPS-dependent proinflammatory mediators post-transcriptionally. Using polysome profiling we now demonstrate conclusively that mycolactone does not prevent translation of TNF, IL-6 and Cox-2 mRNAs in macrophages. Instead, it inhibits the production of these, along with nearly all other (induced and constitutive) proteins that transit through the ER. This is due to a blockade of protein translocation and subsequent degradation of aberrantly located protein. Several lines of evidence support this transformative explanation of mycolactone function. First, cellular TNF and Cox-2 can be once more detected if the action of the 26S proteasome is inhibited concurrently. Second, restored protein is found in the cytosol, indicating an inability to translocate. Third, in vitro translation assays show mycolactone prevents the translocation of TNF and other proteins into the ER. This is specific as the insertion of tail-anchored proteins into the ER is unaffected showing that the ER remains structurally intact. Fourth, metabolic labelling reveals a near-complete loss of glycosylated and secreted proteins from treated cells, whereas cytosolic proteins are unaffected. Notably, the profound lack of glycosylated and secreted protein production is apparent in a range of different disease-relevant cell types. These studies provide a new mechanism underlying mycolactone's observed pathological activities both in vitro and in vivo. Mycolactone-dependent inhibition of protein translocation into the ER not only explains the deficit of innate cytokines, but also the loss of membrane receptors, adhesion molecules and T-cell cytokines that drive the aetiology of Buruli ulcer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Mycolactone inhibits co-translational translocation of proteins into the ER via a mechanism that does not disrupt the structural integrity of the ER. A–E. In vitro translation (IVT) reactions of different capped transcripts were performed as described +/− mycolactone (MYC; 200 ng/ml unless indicated otherwise), Eeyarestatin 1 (ES1; 250 µM) or DMSO (-; 0.02%). Data representative of 3 independent experiments. A. IVT of luciferase and TNF mRNAs detected by 35S incorporation and Western blot (∼26 kDa) respectively. B. IVT of TNF mRNA was performed in the presence of semi-permeabilised RAW264.7 cells then incubated with no addition (-), or Proteinase K (PK) +/−0.1% Triton-x-100 (PKT) for 1 hr at 4°C before stopping the reaction. C. Dose dependence of loss of the PK protected band. Signal intensity was quantified by ImageJ analysis of non-saturated blots and the protected band (PK) was normalised to total pro-TNF (-). D. IVT of prepro-α Factor (PPAF) and β-lactamase (LACTB) mRNAs in the absence or presence of canine pancreatic microsomal membranes (CPMM). Black arrowhead, glycosylated forms of α Factor; *, signal peptide-cleaved LACTB. E. IVT of PPAF, Sec61β and cytochrome B5 (Cyt-B5) mRNAs in the presence CPMM. After labelling with 35S as described, membranes were isolated by centrifugation through a sucrose cushion [31]. Endoglycosidase H (EndoH) is used to confirm glycosylation of proteins (black arrowhead), the thin line represents where an empty lane was removed from the image for ease of interpretation. F. RAW264.7 cells were incubated +/−125 ng/ml mycolactone (MYC), washed and incubated without mycolactone for various periods (recovery time) before stimulating with LPS for 4 hrs. Supernatant TNF levels were measured by ELISA (mean±SEM of triplicate assays).](https://figures.cochat.ai/paper-figures/08c037fe166d42d5b63952ca096a48fd/the-pathogenic-mechanism-of-the-mycobacterium-ulcerans-virulence-factor-figure-4.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, inhibiting the 29S proteasome showed that non-glycosylated TNF accumulates in the cytoplasm of mycolactone-treated macrophages, indicating that this causes the failure in TNF secretion.”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [102]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These findings were made more general by showing that – in many cell types – mycolactone was inhibiting the translocation of several secreted and membrane proteins into the ER.”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [102]
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, Hall et al. found that mycolactone does not cause gross changes in translation, with proinflammatory mRNAs being actively translated (102).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [102]
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, mycolactone blocked the release of several cytokines, chemokines, and other inflammatory mediators from LPS-activated macrophages (102).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [102]
The cited source says what the claim attributes to it.
In the citing paper
“These effects were found not to be due to mycolactone disrupting ER membrane integrity or due to induction of ER-associated degradation pathways.”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [102]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Powley, I. R., Kondrashov, A., Young, L. A., Dobbyn, H. C., Hill, K., Cannell, I. G., Stoneley, M., Kong, Y.-W., Cotes, J. A., Smith, G. C. M., et al. (2009) · Genes & Development · doi:10.1101/gad.516509 · Cited by 150
Self-citationRetractedIngolia, N. T., Lareau, L. F., & Weissman, J. S. (2011) · Cell · doi:10.1016/j.cell.2011.10.002 · Cited by 2,187 · cited 1×
“Puromycin (PURO) causes premature termination and ribosomal release from translating mRNAs, whereas homoharringtonine (HH) prevents translation initiation leading to ribosome run-off of translating mRNAs) [22,23].”
BackgroundX-ray structure of a protein-conducting channel
Berg, B. V. D., Clemons, W. M., Collinson, I., Modis, Y., Hartmann, E., Harrison, S. C., & Rapoport, T. A. (2004) · Nature · doi:10.1038/nature02218 · Cited by 1,250
Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes.
Rapoport, T. A. (2007) · Nature · doi:10.1038/nature06384 · Cited by 977 · cited 1×
“Since TNF and IL-6 are secreted proteins and Cox-2, is ER-resident and contains a signal peptide, their actively-translating, nascent polypeptide chains should be directly associated with the ER due to the interaction of the signal peptide with the signal recognition particle (SRP) and Sec61 complex [24].”
BackgroundInflammasome activation and IL-1β and IL-18 processing during infection
van de Veerdonk, F. L., Netea, M. G., Dinarello, C. A., & Joosten, L. A. B. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.01.003 · Cited by 691 · cited 1×
“and are secreted by an unconventional mechanism following cleavage of the cytosolic pro-isoforms in a caspase- and inflammasome-dependent manner [40].”
Background[6] Preparation of microsomal membranes for cotranslational protein translocation
Walter, P., & Blobel, G. (1983) · Methods in Enzymology · doi:10.1016/s0076-6879(83)96010-x · Cited by 663 · cited 1×
“Where used, canine microsomal membrane (CPMM) preparations (Promega, or prepared in house [58]; a kind gift of Prof Barnhard Dobberstein [University of Heidelberg]) or semi-permeabilised RAW264.”
MethodMycolactone: A Polyketide Toxin from Mycobacterium ulcerans Required for Virulence
George, K. M., Chatterjee, D., Gunawardana, G., Welty, D., Hayman, J., Lee, R., & Small, P. L. C. (1999) · Science · doi:10.1126/science.283.5403.854 · Cited by 641 · cited 2×
“For instance, the delay between injection of even 100 mg of mycolactone into guinea pig and ulcer formation is 5 days [1], although some early signs of apoptosis are evident from 2 days [7].”
BackgroundP2X7 Receptor Differentially Couples to Distinct Release Pathways for IL-1β in Mouse Macrophage
Pelegrin, P., Barroso-Gutierrez, C., & Surprenant, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7147 · Cited by 410 · cited 1×
“S3C) as they lack the required ASC (Apoptotic speck protein containing a caspase recruitment domain [41]), and so they were not studied further here.”
BackgroundWASP: a key immunological multitasker
Thrasher, A. J., & Burns, S. O. (2010) · Nature Reviews Immunology · doi:10.1038/nri2724 · Cited by 406 · cited 1×
“Mutations in human WASP are associated with a range of immune dysfunction disorders and WASP has also been implicated in Golgi to ER transport [45,46].”
BackgroundGiant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans
Stinear, T. P., Mve-Obiang, A., Small, P. L. C., Frigui, W., Pryor, M. J., Brosch, R., Jenkin, G. A., Johnson, P. D. R., Davies, J. K., Lee, R. E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305877101 · Cited by 389 · cited 1×
“immune responses [1,3].”
Cited by
Items 101–166 of 166
Per- and polyfluoroalkyl substances (PFAS) alter immune responses from THP-1 human monocytes
McCall, J. R., Sausman, K. T., & Mead, R. N. (2026) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2026.104938 · Cited by 7
Stereoselective total synthesis and stereochemistry confirmation of photo-mycolactones
Li, X., Babu, V. S., & Kishi, Y. (2014) · Tetrahedron Letters · doi:10.1016/j.tetlet.2014.12.024 · Cited by 8
Kawashima, A., Kiriya, M., En, J., Tanigawa, K., Nakamura, Y., Fujiwara, Y., Luo, Y., Maruyama, K., Watanabe, S., Goto, M., et al. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010672 · Cited by 6
“Mycolactone also prevents the translocation of proteins that pass through the endoplasmic reticulum for secretion or placement in cell membranes [7, 8, 45]; these proteins accumulate and activate ER stress responses [7, 46].”
BackgroundHost Lipid Manipulation by Intracellular Bacteria: Moonlighting for Immune Evasion
Challagundla, N., Phadnis, D., Gupta, A., & Agrawal-Rajput, R. (2023) · The Journal of Membrane Biology · doi:10.1007/s00232-023-00296-8 · Cited by 6
“M. tuberculosis releases mycolactone, which inhibits translocation of TNFα to ER lumen inhibiting its secretion (Hall et al. 2014).”
BackgroundDhungel, L., Burcham, L. R., Park, J. Y., Sampathkumar, H. D., Cudjoe, A., Seo, K. S., & Jordan, H. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-89177-5 · Cited by 6
Sorout, N., & Helms, V. (2024) · Journal of Molecular Recognition · doi:10.1002/jmr.3108 · Cited by 6
“This indicates a selective effect of mycolactone on ER protein import unlike the structurally unrelated compound apratoxin A that was shown to have a nonselective effect on ER protein import [7, 111, 113, 140, 141].”
Akolgo, G. A., Asiedu, K. B., & Amewu, R. K. (2024) · Toxins · doi:10.3390/toxins16120528 · Cited by 7
“Despite these findings, the mechanism behind the linkage between mycolactone translocation blockage and apoptosis-induced cell death remained unclear.”
InfluentialBernard, Q., Goumeidane, M., Chaumond, E., Robbe-Saule, M., Boucaud, Y., Esnault, L., Croué, A., Jullien, J., Marsollier, L., & Marion, E. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011479 · Cited by 5
“Mycolactone toxicity is dependent on the ability of this toxin to bind Sec61, a protein located in the endoplasmic reticulum (ER) membrane of host cells [6].”
BackgroundRobeson, L., Casanova‐Morales, N., Burgos‐Bravo, F., Alfaro‐Valdés, H. M., Lesch, R., Ramírez-Álvarez, C. E., Valdivia‐Delgado, M., Vega, M., Matute, R. A., Schekman, R. W., et al. (2024) · Protein Science · doi:10.1002/pro.4996 · Cited by 4
“We worked at a final concentration of 0.5 μ g/mL, above the 0.1 μ g/mL reported to have saturated inhibitory activity in vivo (Hall et al., 2014).”
BackgroundMethodInfluentialProtein translocation through α-helical channels and insertases
Chen, J., Zhou, X., Yang, Y., & Li, L. (2024) · Structure · doi:10.1016/j.str.2024.10.032 · Cited by 5
A putative lncRNA RBM26-AS1-encoded micropeptide promotes colon cancer progression
Wu, Q., & Ji, Z. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002834 · Cited by 5
“Among these molecules that may interact with micropeptide, SEC61A1/SEC61 α (SEC61 translocon subunit alpha 1), a core component of the heterotrimeric SEC61 complex, plays a crucial role in the transport of secretory proteins and transmembrane proteins into the endoplasmic reticulum [ 23 , 24 ] .”
Can membrane composition traffic toxins? Mycolactone and preferential membrane interactions
da Hora, G. C. A., Nguyen, J. D. M., & Swanson, J. M. J. (2022) · Biophysical Journal · doi:10.1016/j.bpj.2022.10.019 · Cited by 7
Current Progress and Prospects for a Buruli Ulcer Vaccine
Boakye-Appiah, J. K., Hall, B. S., Reljić, R., & Simmonds, R. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-24355-4_5 · Cited by 6
Self-citationLim, B., Shadid, O. H., Novo, J., Mon, Y., Seth, I., Marcaccini, G., Cuomo, R., O'Brien, D. P., & Rozen, W. M. (2025) · Life · doi:10.3390/life15071096 · Cited by 4
“Mycobacterium ulcerans pathogenesis is primarily driven by mycolactone, a polyketide toxin that causes tissue necrosis and immune suppression, enabling the bacterium to persist extracellularly in subcutaneous tissue [16–19].”
Genetics in the Host‐Mycobacterium ulcerans interaction
Fevereiro, J., Fraga, A. G., & Pedrosa, J. (2021) · Immunological Reviews · doi:10.1111/imr.12958 · Cited by 5
“…yet to be described in public human databases.95,97- 99 A compilation of the experimentally validated TMPs affected by mycolactone can be found in Hall et al 2014,100 but odds are that the majority of membrane receptors and molecules secreted by mammalian cells are affected as well.95,97 These…”
BackgroundKim, D., Crippen, T. L., Dhungel, L., Delclós, P. J., Tomberlin, J. K., & Jordan, H. R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289768 · Cited by 4
Buruli Ulcer: Case Study of a Neglected Tropical Disease
Benbow, M. E., Simmonds, R. E., Merritt, R. W., & Jordan, H. R. (2017) · Advances in environmental microbiology · doi:10.1007/978-3-319-60616-3_5 · Cited by 3
Self-citationBiogenesis of TNF ‐α‐insights into proteostasis and inflammation
Haidar, B., Philippe, C., Chevet, É., & Zahradník, J. (2026) · FEBS Journal · doi:10.1111/febs.70553 · Cited by 3
Boakye-Appiah, J. K., Tran, A. C., Paul, M. J., Hart, P. J., Phillips, R. O., Harrison, T. S., Wansbrough-Jones, M. H., & Reljić, R. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012710 · Cited by 4
“These mouse trials involving several antigenic candidates [19,20] have demonstrated partial protection at best [21].”
Synthesis, Biological Evaluation and Docking Studies of Ring-Opened Analogues of Ipomoeassin F
O’Keefe, S. M., Bhadra, P., Duah, K. B., Zong, G., Tenay, L., Andrews, L., Schneider, H. O., Anderson, A., Hu, Z., Aljewari, H., et al. (2022) · Molecules · doi:10.3390/molecules27144419 · Cited by 3
“structurally distinct classes of natural products: apratoxins [27], coibamide A [28], cotransins [29], decatransin [30], mycolactone [31,32] and derivatives thereof [24,25].”
BackgroundSelf-citationAyerakwa, E. A., Abban, M. K., Isawumi, A., & Mosi, L. (2023) · Future Science OA · doi:10.2144/fsoa-2022-0044 · Cited by 3
“Ulceration and an eventual cell loss result from induced apoptosis caused by inhibition of protein translocation into the endoplasmic reticulum and cell detachment [19] .”
BackgroundSur, S., & Pal, B. (2022) · Acta Biologica Szegediensis · doi:10.14232/abs.2021.2.233-245 · Cited by 3
Loglo, A. D., Antwi, P. B., Abass, K. M., Mireku, S. O., Amofa, G., Ofori, E., Adjei, J. K., Oppong, M. N., Phillips, R. O., Annan, R. A., et al. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012871 · Cited by 4
“A pathogen-derived exotoxin, mycolactone, is known to play a central role in disease pathogenesis [4,5] due to its blockade the Sec61 translocon [6] underpinning its cytotoxic and immunosuppressive activities [7] as well as its induction of vascular dysfunction [8].”
Self-citationNeglected Tropical Bacterial Diseases
Saxena, A. K., & Azad, C. S. (2016) · Topics in medicinal chemistry · doi:10.1007/7355_2016_5 · Cited by 3
Hsieh, L. T.-H., Hall, B. S., Newcombe, J., Mendum, T. A., Santana‐Varela, S., Umrania, Y., Deery, M. J., Shi, W. Q., Díaz‐Delgado, J., Salguero, F. J., et al. (2024) · eLife · doi:10.7554/elife.86931.2 · Cited by 3
Self-citationDifferential time-restricted sensitivity of enveloped viruses to Sec61 translocon blockadePreprint
Eke, L., Hall, B. S., Thorne, L., Ebert, K., Kerfoot, L., Towers, G. J., Simmonds, R. E., & Elliott, G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.03.636181 · Cited by 3
Self-citationPhelippeau, M., Marion, E., Robbe-Saule, M., Ganlanon, L., Chauty, A., Adeye, A., Blanchard, S., Johnson, C. R., Marsollier, L., & Dubée, V. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad176 · Cited by 2
“[5]) and Australia (32 of 156 [21”
Nguyen, J. D. M., da Hora, G. C. A., & Swanson, J. M. J. (2023) · Toxins · doi:10.3390/toxins15080486 · Cited by 2
“This is consistent with other studies showing that mycolactone’s main cytotoxic and immunosuppressive effects result from its inhibition of the Sec61 translocon [6], a membrane-embedded protein complex (Figure 2) that translocates precursor polypeptides into the ER for processing [1].”
BackgroundResultInfluentialInflammasome-triggered IL-18 controls skin inflammation in the progression of Buruli ulcer
Suzuki, T., Boonyaleka, K., Okano, T., Iida, T., Yoshida, M., Fukano, H., Hoshino, Y., Iwakura, Y., Ablordey, A. S., & Ashida, H. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011747 · Cited by 2
“These biological actions of mycolactone are exerted via toxin-mediated interference to Sec61 translocon, which results in inhibition of Sec61-dependent co-translational translocation of newly synthesized proteins into the endoplasmic reticulum (ER) [12].”
BackgroundResultBuDb: A Curated Drug Discovery Database for Buruli Ulcer
Kwofie, S. K., Anyimadu, D. T., Aryee, S., Asare, B., Kokroko, N., Owusu, J. A., Afutu, B., Agyapong, O., Mosi, L., Kyei-Baffour, E. S., et al. (2022) · Journal of Computational Biophysics and Chemistry · doi:10.1142/s2737416523500011 · Cited by 2
Membrane Active Immunomodulator As a Novel Therapy for an Infectious Bacterial Disease, Buruli Ulcer
Izbicka, E., Streeper, R. T., & Louden, C. (2022) · In Vivo · doi:10.21873/invivo.12996 · Cited by 3
Hsieh, L. T.-H., Hall, B. S., Newcombe, J., Mendum, T. A., Umrania, Y., Deery, M. J., Shi, W. Q., Salguero, F. J., & Simmonds, R. E. (2023) · eLife · doi:10.7554/elife.86931.1 · Cited by 2
Self-citationBuruli Ulcer Transmission: Environmental Pathways and Implications for Dermatologic Care
Anthony, M. R. (2024) · Cutis · doi:10.12788/cutis.1145 · Cited by 1
Khosravi, A., Nnamdi, P., May, A., Slattery, K., Sammelson, R. E., & Shi, W. Q. (2025) · Molecules · doi:10.3390/molecules30020400 · Cited by 1
“…can be classified into four categories: depsipeptides (cotransin (Figure 1) [7], coibamide A [8], and decatransin [9]), polyketides (mycolactone A/B (Figure 1) [10,11]), hybrid of depsipeptides and polyketides (apratoxins (Figure 1) [12,13]), and glycolipids (ipomoeassin F (Ipom-F, Figure 1) [14]).”
Rules of Engagement for Components of Membrane Protein Biogenesis at the Human Endoplasmic Reticulum
Zimmermann, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188823 · Cited by 1
Paillares, E., Deboosère, N., Descorps‐Declère, S., Marechal, M., Gillet, D., Demangel, C., Mettouchi, A., Brodin, P. M., & Lemichez, E. (2025) · mBio · doi:10.1128/mbio.02585-24 · Cited by 1
“Remarkably, Sec61 can be specifically inhibited by mycolactone, a polyke tide produced by Mycobacterium ulcerans (35–37).”
The dual role of the microbiome in chronic wound management
Deng, R., Qian, J., Liu, Y., Bu, Q., 曹廷军, Gao, M., & Huang, Z. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02937-6 · Cited by 2
“It directly induces apoptosis and necrosis in cutaneous and subcutaneous cells while suppressing local immune responses, thus creating a conducive environment for bacterial proliferation [86, 87].”
Multiple facets and functions of the toxin mycolactone produced by Mycobacterium ulcerans
Foulon, M., Fraga, A. G., Yeramian, E., Pedrosa, J., & Marsollier, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91948-7.00008-7 · Cited by 1
Therapeutic efficacy of rifalazil (KRM-1648) in a M. ulcerans-induced Buruli ulcer mouse model
Fukano, H., Nakanaga, K., Goto, M., Yoshida, M., Ishii, N., & Hoshino, Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274742 · Cited by 1
Salmonella virulence factors and their role in intracellular parasitism
Moest, T. (2014) · theses.fr (ABES) · doi:10.70675/55356c06ze3baz4f8ez9796zaf68908f049e · Cited by 1
Lepra und Buruli-Ulkus: Bedeutung der „vernachlässigten tropischen Erkrankungen“ für Kinder weltweit
Adamczick, C., & Schwienhorst-Stich, E. (2015) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-015-3378-8
Mechanism underpinning the immunosuppressive effects of the mycobacterial macrolide mycolactone
Morel, J. (2018) · theses.fr (ABES) · doi:10.70675/2122074fz09e9z4c6bz84cfzb4d151f34942
Mycolactone is toxic to cultured Schwann cells - mechanism of nerve damage in Buruli ulcer
En, J. (2019) · Japanese journal of leprosy · doi:10.5025/hansen.87.123
O’Keefe, S. M., Bhadra, P., Duah, K. B., Zong, G., Tenay, L., Andrews, L., Schneider, H. O., Anderson, A., Hu, Z., Aljewari, H., et al. (2022) · ChemRxiv · doi:10.26434/chemrxiv-2022-sc5xv
Self-citationJohnson, D. I. (2017) · Springer eBooks · doi:10.1007/978-3-319-67651-7_7
Hsieh, L. T.-H., Hall, B. S., Newcombe, J., Mendum, T. A., Umrania, Y., Deery, M. J., Shi, W. Q., Salguero, F. J., & Simmonds, R. E. (2023) · eLife · doi:10.7554/elife.86931.1.sa4
Self-citationInhibition du translocon Sec61 dans le traitement du myélome multiple
Domenger, A. (2023) · theses.fr (ABES) · doi:10.70675/dcf9f581z3c86z4899zb108z2cd66f0a0216
Larsson, S. (2023) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/180359 · Cited by 2
A mycobacterial Sec61 inhibitor disrupts lysosome function by blocking Vacuolar-ATPase biosynthesis
Hall, B. S., Owusu-Boateng, K., McPhail, K. L., Shi, W. Q., & Simmonds, R. E. (2026) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2026.151541
Self-citation(2019) · OAPEN (The OAPEN Foundation)
Buruli Ulcer : Mycobacterium Ulcerans Disease
(2019) · OAPEN (The OAPEN Foundation)
(2019) · Directory of Open access Books (OAPEN Foundation)
Saint-Auret, S. (2017) · theses.fr (ABES) · doi:10.70675/a2750d2bz1209z427bz8ae0zee7524dfe4ff · Cited by 1
Les sources et les réservoirs de Mycobacterium ulcerans, agent causal de l'ulcère de Buruli
Bouam, A. (2018) · theses.fr (ABES) · doi:10.70675/99957420zec33z4e54zb6d1zf3937ac2416e
Membrane-protein interactions regulate excitability through potassium and chloride channels
Prado, P. Á. (2020) · theses.fr (ABES) · doi:10.70675/51de046dzedc7z4143za027z80e2a9dfcea9
Hervouet, K. (2022) · theses.fr (ABES) · doi:10.70675/81dd4ae5z5ca7z46e1za8d5z996c9380558c
Modelling the formation of skin ulcers observed in Buruli ulcer diseasePreprint
Atuhaire, F., Simmonds, R. E., & Hoyle, R. B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.06.757134
“The predominant mechanism by which mycolactone drives BU is due to its ability to block the action of the essential cellular molecule Sec61 [13,14].”
InfluentialSelf-citationN-terminal Trimming Supports Proteostasis Under Secretory Protein Mislocalization StressPreprint
Castellanos, J. P., Nguyen, K. K., Lin, Q., Lyu, Z., Yang, Z., Sarwono, F., Gonzalez, J. C., Nguyen, W., Huynh, L. T., Canizal, C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.13.756067
“Most reports have found that XBP1s and RIDD are activated during Sec61 inhibition, with one report finding XBP1s is not activated by mycA/B. 10,22,29,33,34 We do not see XBP1s activation by SW3 or mycA/B, though there is mild reduction of RIDD targets ( Supplemental Figure S1G ).”
Metadata
- Authors
- Hall, B. S., Hill, K., McKenna, M., Ogbechi, J., High, S., Willis, A. E., & Simmonds, R. E.
- Affiliations
- University of Surrey (GB)
- Babraham Institute (GB)
- University of Manchester (GB)
- Corresponding author
- Simmonds, Rachel E.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-04-03
- Volume
- 10
- Issue
- 4
- Pages
- e1004061
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3974873
- OpenAlex
- W2061277860
- Semantic Scholar
- 5212d6d5ae6ba36ce1c7bcab6a815efbff42e4ad
- Cited by
- 162
- References
- 61
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 6 · 2023: 24 · 2022: 16 · 2021: 14 · 2020: 12 · 2019: 17 · 2018: 15 · 2017: 13 · 2016: 7 · 2015: 12 · 2014: 9
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Harvard University
- Wellcome Trust (WT092744)
- Biotechnology and Biological Sciences Research Council (BB/F02326X/2, 1338405, 1626839)
- Topics
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
- Keywords
- Mycobacterium ulcerans, mycolactone, Buruli ulcer, virulence factors, protein translocation, endoplasmic reticulum, protein degradation, 26S proteasome, TNF-α, interleukin-6, cyclooxygenase-2, macrophages, glycosylated proteins, secreted proteins, immunosuppression, tissue necrosis, post-transcriptional regulation
- MeSH terms
- Animals, Cell Line, Endoplasmic Reticulum, Lipopolysaccharides, Protein Biosynthesis, Tumor Necrosis Factor-alpha, Cell Adhesion Molecules, Interleukin-6, Inflammation Mediators, Macrolides, Mycobacterium ulcerans, Protein Transport, Mice, Cyclooxygenase 2, Buruli Ulcer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.